Table 3.
PCT1 | PCT2 | PCT3 | |
---|---|---|---|
NRT | 40.0% (104/260)* | 52.0% (116/223) | 54.3% (138/254) |
Varenicline | 60.2% (59/98) | 81.0% (111/137) | 68.6% (70/102) |
Bupropion | 90.9% (10/11) | 75.0% (12/16) | 37.5% (3/8) |
None | 41.6% (10/24) | 56.5% (13/23) | 35.5% (11/31) |
*This result represents a combination of monotherapy (53/112; 47%) and dual therapy (51/148; 34%).